RecruitingNot ApplicableNCT06843720

Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems


Sponsor

M.D. Anderson Cancer Center

Enrollment

7,100 participants

Start Date

Feb 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial is expanding access to cervical cancer screening in Texas safety-net health clinics by offering HR-HPV primary testing (a more sensitive test) and at-home self-sampling kits, especially for women who face barriers to getting a traditional Pap smear. You may be eligible if: you are a woman or person with a cervix; you are between 25 and 65 years old; you live in Texas; you are seen at a participating clinic; and you are due or overdue for cervical cancer screening. You may NOT be eligible if: you are currently pregnant; you have had a total hysterectomy (cervix removed); or you have a history of cervical cancer. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHR-HPV Testing

Given by Interview and focus groups


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06843720